,
2 min read
In the dynamic world of pharmaceuticals and life sciences, maintaining compliance with Good Manufacturing Practice (GMP) and global quality standards is not just a regulatory requirement — it’s a business imperative. As India continues to emerge as a global manufacturing hub for pharmaceuticals, facility audits play a crucial role in ensuring that organizations remain inspection-ready for both domestic and international markets.
That’s where Freyr Solutions comes in — offering end-to-end Facility Audit Services in India designed to help you meet regulatory expectations, reduce compliance risks, and strengthen your global credibility.
What Are Facility Audit Services?
A facility audit is a systematic, independent assessment of your manufacturing site, systems, and processes against applicable regulatory and quality standards — such as WHO-GMP, USFDA, EMA, MHRA, TGA, or Schedule M requirements.
Audits cover multiple aspects of pharmaceutical and biotech operations, including:
- Quality management systems (QMS)
- Documentation and data integrity
- Equipment and utilities qualification
- Process validation
- Cleaning and environmental controls
- Training and personnel competencies
A well-executed audit not only identifies gaps but also provides actionable insights for continuous improvement — ensuring facilities are compliant, efficient, and inspection-ready.
Freyr’s Comprehensive Facility Audit Capabilities
Freyr Solutions offers end-to-end facility audit services tailored for pharmaceuticals, biologics, cosmetics, and medical devices. Our experts bring years of experience working with global health authorities, giving clients the edge needed to meet stringent regulatory expectations.
- Pre-Audit Readiness Assessments – Evaluate systems and documentation before formal inspections to minimize compliance gaps.
- GMP & GCP Compliance Audits – Verify adherence to national and international regulatory frameworks.
- Mock Inspections & CAPA Implementation – Simulate regulatory inspections and guide clients in developing Corrective and Preventive Actions (CAPA).
- Vendor & Supplier Audits – Assess third-party manufacturing sites, API suppliers, and packaging units for compliance assurance.
- Post-Audit Support – Assistance with audit reports, CAPA closure, and re-inspection readiness.
Why Choose Freyr for Facility Audits in India?
Freyr’s Regulatory and Quality experts understand both local and global expectations. With a strong presence in India and worldwide, Freyr offers:
- Multidisciplinary expertise across pharma, biotech, and medical devices
- In-depth knowledge of CDSCO, WHO, USFDA, EMA, and other regulatory frameworks
- Data-driven audit methodologies ensuring objectivity and accuracy
- Action-oriented insights for rapid remediation and compliance improvement
Whether you are preparing for an international inspection, qualifying a new facility, or conducting internal compliance checks — Freyr’s audit team ensures you’re always inspection-ready.
Freyr: Your Partner for Compliance and Confidence
In a market where regulatory scrutiny is increasing, proactive compliance through facility audits gives you a competitive edge. Freyr Solutions helps you detect gaps before regulators do, ensuring smooth inspections, uninterrupted operations, and faster approvals.
Stay compliant. Stay confident. Stay ahead with Freyr.
Connect with Freyr Solutions today to schedule your next Facility Audit in India and ensure your operations meet the highest global standards.
